Prostate Cancer Update

52:24

Prostate Cancer with PTEN Deficiency — An Interview...

Prostate Cancer Update ·

2026/10/03

Featuring an interview with Dr Neeraj Agarwal, including the following topics:Impact of PTEN deficiency on PI3K/AKT/mTOR pathway; optimal approaches to testing (0:00)Approaches to monitoring for disease progression in patients who are PTEN deficient; prognostic significance and implications for testing (7:13)Potential usage of capivasertib as second-line therapy for metastatic androgen pathway modulation-naïve/-sensitive (APMN/S) prostate cancer (15:15)Managing treatment-related adverse events from

en

25:57

Metastatic Bladder Cancer — Rapid Case Review Issue 8

Prostate Cancer Update ·

2026/09/16

Featuring perspectives from Dr Alexandra Drakaki, including the following topics:Case: A man in his late 70s with diabetes and metastatic bladder cancer achieves radiographic response with enfortumab vedotin (EV) and pembrolizumab but develops uncontrolled hyperglycemia (0:00)Case: A man in his early 70s with muscle-invasive bladder cancer receives adjuvant nivolumab and experiences metastatic progression after 9 cycles of therapy (6:23)Case: A woman in her early 70s with Lynch syndrome and

en

36:28

Metastatic Bladder Cancer — Rapid Case Review Issue 7

Prostate Cancer Update ·

2026/09/16

Featuring perspectives from Dr Alexandra Drakaki, including the following topics:Case: A man in his early 80s with bladder cancer and metastatic progression in the viscera and lymph nodes receives enfortumab vedotin (EV) with pembrolizumab — Part 1 (0:00)Case: A man in his early 80s with metastatic bladder cancer achieves a complete response with EV/pembrolizumab therapy but develops gastrointestinal toxicity — Part 2 (5:37)Case: A man in his early 50s with metastatic bladder cancer receives

en

59:11

Prostate Cancer — The Optimal Use of Hormonal Therapy

Prostate Cancer Update ·

2026/09/08

Featuring perspectives from Dr William K Oh and Dr Mary-Ellen Taplin, including the following topics:Introduction: Another Perspective on the Treatment of Localized Prostate Cancer (0:00)Nonmetastatic Disease (10:32)Metastatic Androgen Pathway Modulation-Naïve and Androgen Pathway Modulation-Sensitive Disease (41:50)CME information and select publications

en

17:37

AKT Inhibition in Prostate Cancer — Microlearning...

Prostate Cancer Update ·

2026/09/05

Featuring perspectives from Dr Karim Fizazi, Dr Daniel George and Dr Elisabeth I Heath, moderated by Dr Heath, including the following topics:Tolerability of capivasertib and management of associated side effects — Question from Neeraj Agarwal, MD, FASCO (0:00)Case: A man in his early 70s with Type 2 diabetes presents with metastatic hormone-sensitive prostate cancer with widespread bone metastases and PTEN deficiency on next-generation sequencing and receives relugolix/darolutamide — Rana R McKay,

en

01:28:06

For Oncology Nurses: Prostate Cancer — Proceedings...

Prostate Cancer Update ·

2026/08/31

Featuring perspectives from Mr Michael Lai, Dr Scott T Tagawa, Ms Stacy E Walker and Dr Evan Y Yu, moderated by Dr Tagawa, including the following topics:Introduction (0:00)Overview of Prostate Cancer (3:00)Hormonal Therapy for Nonmetastatic and Metastatic Hormone-Sensitive Prostate Cancer (HSPC) (6:12)Potential Role of Capivasertib in Metastatic HSPC (27:22)Current and Potential Future Role of PARP Inhibitors in Metastatic PC (46:39)Current and Future Role of Lutetium Lu 177 Vipivotide Tetraxetan

en

15:13

Non-Muscle-Invasive and Muscle-Invasive Bladder...

Prostate Cancer Update ·

2026/08/27

Featuring perspectives from Dr Terence Friedlander, Dr Matthew Galsky, Dr Shilpa Gupta and Prof Andrea Necchi, moderated by Dr Friedlander, including the following topics:Case: A patient with T4 disease, pelvic wall involvement and a positive pelvic node treated as metastatic disease with enfortumab vedotin and pembrolizumab attains a complete response on imaging after 6 cycles (0:00)Case: A man with muscle-invasive bladder cancer who receives neoadjuvant chemotherapy with durvalumab receives

en

20:16

Non-Muscle-Invasive and Muscle-Invasive Bladder...

Prostate Cancer Update ·

2026/08/26

Featuring perspectives from Dr Terence Friedlander, Dr Matthew Galsky, Dr Shilpa Gupta and Prof Andrea Necchi, moderated by Dr Friedlander, including the following topics:Case: A man in his early 80s with non-muscle-invasive bladder cancer (NMIBC) monitored by repeat TURBTs develops localized muscle-invasive bladder cancer and enrolls in a clinical trial of neoadjuvant enfortumab vedotin with pembrolizumab (0:00)Case: A man in his late 70s with newly diagnosed NMIBC with carcinoma in situ (CIS)

en

18:57

AKT Inhibition in Prostate Cancer — Microlearning...

Prostate Cancer Update ·

2026/08/22

Featuring perspectives from Dr Karim Fizazi, Dr Daniel George and Dr Elisabeth I Heath, moderated by Dr Heath, including the following topics:Treatment approach for AKT-mutated prostate cancer — Question from Neeraj Agarwal, MD, FASCO (0:00)Case: A man in his late 60s with de novo metastatic hormone-sensitive prostate cancer with widespread skeletal metastases and PTEN loss on next-generation sequencing receives relugolix/darolutamide with chemotherapy and experiences PSA decline that plateaus at

en

16:56

AKT Inhibition in Prostate Cancer — Microlearning...

Prostate Cancer Update ·

2026/08/21

Featuring perspectives from Dr Karim Fizazi, Dr Daniel George and Dr Elisabeth I Heath, moderated by Dr Heath, including the following topics:Role of PTEN deficiency in tumorigenesis of prostate cancer and optimal approach to PTEN assessment — Question from Neeraj Agarwal, MD, FASCO (0:00)Case: A man in his late 60s with a history of nonmetastatic hormone-sensitive prostate cancer (HSPC) that progressed to metastatic HSPC with PTEN loss by next-generation sequencing of primary archival tissue from

en

01:30:11

Genitourinary Cancers — Reviewing Key Presentations...

Prostate Cancer Update ·

2026/08/19

Featuring perspectives from Dr Rahul Aggarwal, Dr Matthew D Galsky and Dr Tian Zhang, including the following topics:Introduction: Welcome GU Oncology Fellows! (0:00)Prostate Cancer — Dr Aggarwal (12:48)Urothelial Bladder Cancer — Dr Galsky (45:01)Renal Cell Carcinoma — Dr Zhang (1:10:52)CME information and select publications

en

25:48

Metastatic Bladder Cancer — Rapid Case Review Issue 6

Prostate Cancer Update ·

2026/08/18

Featuring perspectives from Prof Yohann Loriot, including the following topics:Case: A man in his early 80s with metastatic urothelial bladder cancer (mUBC) receives enfortumab vedotin (EV)/pembrolizumab but experiences immune-related adverse events requiring steroids and then develops neuropathy due to EV — Nazli Dizman, MD (0:00)Case: A man in his early 70s with diabetes who received adjuvant nivolumab for FGFR3-mutant metastatic urothelial cancer receives first-line EV monotherapy and experiences

en

28:40

Metastatic Bladder Cancer — Rapid Case Review Issue 5

Prostate Cancer Update ·

2026/08/17

Featuring perspectives from Prof Yohann Loriot, including the following topics:Case: A man in his early 80s with Parkinson disease and a history of renal transplant presents with metastatic urothelial bladder cancer (UBC) and receives first-line enfortumab vedotin (EV) with a good response but develops neuropathy and skin toxicity — Jacqueline T Brown, MD (0:00)Case: A man in his early 90s with excellent PS and locally advanced UBC receives EV and pembrolizumab as palliative treatment, develops

en

20:22

Non-Muscle-Invasive and Muscle-Invasive Bladder...

Prostate Cancer Update ·

2026/08/15

Featuring perspectives from Dr Terence Friedlander, Dr Matthew Galsky, Dr Shilpa Gupta and Prof Andrea Necchi, moderated by Dr Friedlander, including the following topics:Case: A woman in her late 60s with T3N0 upper tract urothelial carcinoma that was resected has no evidence of disease on imaging, receives negative circulating tumor DNA results and elects observation instead of adjuvant treatment (0:00)Case: A man in his late 70s with PD-L1-negative high-grade muscle-invasive bladder cancer who is

en

22:47

Non-Muscle-Invasive and Muscle-Invasive Bladder...

Prostate Cancer Update ·

2026/08/14

Featuring perspectives from Dr Terence Friedlander, Dr Matthew Galsky, Dr Shilpa Gupta and Prof Andrea Necchi, moderated by Dr Friedlander, including the following topics:Case: A healthy man in his early 70s who received several different lines of therapy for non-muscle-invasive bladder cancer (NMIBC), wants to avoid radical cystectomy and does not want pembrolizumab (0:00)Case: A man in his late 70s with newly diagnosed NMIBC with carcinoma in situ (11:20)CME information and select publications

en

01:59:07

Prostate Cancer — Proceedings from a Session Held in...

Prostate Cancer Update ·

2026/08/12

Featuring perspectives from Dr Wassim Abida, Dr Rahul Aggarwal, Dr Emmanuel S Antonarakis, Prof Karim Fizazi and Dr Rana R McKay, moderated by Dr McKay, including the following topics:Introduction (0:00)Evolving Management of Nonmetastatic Hormone-Sensitive Prostate Cancer (HSPC) — Dr Antonarakis (2:42)Current and Future Hormonal Treatment for Metastatic HSPC (mHSPC) — Dr Aggarwal (26:23)Current and Future Role of Regimens Combining PARP Inhibitors and Androgen Receptor (AR) Pathway Inhibitors in

en

35:58

Androgen Deprivation Therapy for Prostate Cancer — An...

Prostate Cancer Update ·

2026/07/02

Featuring an interview with Dr Rana R McKay, including the following topics:Prostate Cancer Working Group (PCWG4) revised terminology (0:00)Cardiovascular effects associated with GnRH agonists versus antagonists; mechanism of action (2:17)Combination therapy using relugolix; factors affecting persistence and adherence to GnRH agents (12:06)Takeaways from the Phase III EMBARK study (19:36)Use of CAR (chimeric antigen receptor) T-cell therapy and T-cell engagers (27:20)Potential role of circulating

en

01:30:07

For Oncology Nurses: Non-Muscle-Invasive and...

Prostate Cancer Update ·

2026/07/01

Featuring perspectives from Dr Alexandra Drakaki, Ms Krisztina Emodi, Dr Terence Friedlander and Ms Margarita Huober, moderated by Dr Friedlander, including the following topics:Introduction: Basic Biology of Nonmetastatic Urothelial Bladder Cancer (UBC) (0:00)Systemic Therapy for Cisplatin-Eligible Patients with Muscle-Invasive Bladder Cancer (MIBC) (13:35)Evolving Approach to Systemic Therapy for Cisplatin-Ineligible Patients with MIBC (37:13)Immune Checkpoint Inhibitors in Non-Muscle-Invasive

en

57:36

Urothelial Bladder Cancer — Year in Review Series on...

Prostate Cancer Update ·

2026/06/25

Featuring perspectives from Dr Ashish M Kamat and Prof Thomas Powles, including the following topics:Introduction: Life After Radical Cystectomy (0:00)Muscle-Invasive Bladder Cancer — Prof Powles (9:15)Non-Muscle-Invasive Bladder Cancer — Dr Kamat (37:49)CME information and select publications

en

49:54

Prostate Cancer — Fifth Annual National General...

Prostate Cancer Update ·

2026/06/23

Featuring perspectives from Dr Neeraj Agarwal and Dr Alan H Bryce, including the following topics:Introduction (0:00)Optimizing the Role of Hormonal Therapy in the Care of Patients with Prostate Cancer — Dr Bryce (2:41)Other Available and Emerging Therapeutic Approaches — Dr Agarwal (35:16)CME information and select publications

en

All Episodes

Similar Podcasts

Rabbit Hole of Research

Jotham Austin, II PhD, Nick Elizalde,...

跨国串门儿计划

yikai

The Grave Talks | Haunted, Paranormal & Supernatural

Ghost Stores, Haunted, Paranormal &...

Real Ghost Stories Online

Real Ghost Stories Online | Paranormal,...

Sleep Science

Sleep Science